(Q33377558)
Statements
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics (English)
Ahmad Awada
Christel Fontaine
Luc Dirix
Christos Sotiriou
Chiaki Tanaka
Ulrike Zoellner
Pui Tang
Martine Piccart
26 November 2007